Globestar Therapeutics Enters into MOU with Advanced

New Post Public Reply Private Reply Replies (1) Message Board
Lee Adams
213
Globestar Therapeutics Enters into MOU with Advanced Innovative Partners to Develop Clinical Studies for Multiple Sclerosis Treatment

RICHLAND, WA and PALM BEACH, FL / ACCESSWIRE / June 14, 2023 / GlobeStar Therapeutics Corporation (OTC PINK:GSTC) (GSTC), a clinical-stage pharmaceutical company focused on advancing new therapies for Multiple Sclerosis (MS) and other neurological diseases, and Advanced Innovative Partners (AIP), a clinical-stage pharmaceutical company focusing on the development of therapeutics and diagnostics, today announced that they have entered into a memorandum of understanding collaboration agreement to design and implement clinical trials for Project Amethyst™, a compound intended to treat neurodegeneration from Multiple Sclerosis (MS). GSTC is the exclusive worldwide licensee for Project Amethyst™, including all patents and patent applications relating thereto, including U.S. Patent #10610592.

James C. Katzaroff, President and CEO of GlobeStar Therapeutics Corporation stated, "Given AIP's strong global relationships with universities, medical associations and hospitals, with its considerable experience in clinical trials, we are delighted that AIP will collaborate with GlobeStar to advance trials for Project Amethyst™. My relationship with AIP's founder, Stanley Satz extends over decades, and I am grateful for his and AIP's support."

Stanley Satz, PhD., AIP's Chairman and Chief Science Officer said: "Our team has considerable domestic and international experience implementing clinical trials for radiopharmaceuticals and other therapies with world renowned colleagues in the areas of oncology, rare pediatric diseases, infectious disease and biomedical countermeasures. We were impressed with the clinical results obtained in Italy for treatment of Multiple Sclerosis patients using Project Amethyst™. These results provide a good foundation for establishing more comprehensive clinical trials with AIP's partners. We are thrilled to advance the opportunities for Project Amethyst™."

The implementation of the Memorandum of Understanding is subject to the execution of definitive agreements and other customary conditions. After these conditions are met, the MOU contemplates that GSTC will lead the effort, contribute related rights to Project Amethyst™, and have primary responsibility for financing, supply chain, manufacturing, and sales, while AIP will introduce potential partners to collaborate in the clinical study, manufacturing and distribution.

About GlobeStar Therapeutics

GlobeStar Therapeutics Corporation (OTC PINK:GSTC) (GSTC)'s mission is to pioneer biotechnology in transformative therapies for the management of chronic neurodegenerative diseases. In an initial study of Project Amethyst™ in Italy of 150 volunteers, 90 between 25 and 65 years of age with MS disease and 60 healthy volunteers, the average Expanded Disability Status Scale (EDSS) score for subjects with MS dropped by at least 1.3 points for pre-treatment and an average of 4.02 points after treatment. After 45 days of treatment, all subjects reported an improvement in balance and motor control of all extremities, and most reported an improvement in bladder control. GSTC is the exclusive global licensee of the Project Amethyst™ patents and patent applications. For additional information see: www.globestartherapeutics.com

About Advanced Innovative Partners

Advanced Innovative Partners is a private clinical stage company focused on developing therapeutic and diagnostic radiopharmaceuticals for oncology, rare pediatric diseases, infectious disease and biomedical countermeasures The company's robust nuclear medicine product portfolio includes specialty pharmaceuticals enabling personalized medicine. For additional information about AIP please visit www.advancedinnovativepartners.com

NOTICE REGARDING FORWARD-LOOKING STATEMENTS

This news release contains forward-looking information within the meaning of Section27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements that include the words believe, expects, anticipates, or similar expressions. Such forward-looking statements involve known and unknown risks, and other factors that may cause the actual results, performance, or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contact:

James Katzaroff

jim@katzaroff.com

509.531.1671

SOURCE: GlobeStar Therapeutics Corporation


View source version on accesswire.com:

https://www.accesswire.com/761240/Globestar-T...-Treatment

GlobeStar Therapeutics Corporation (GSTC) Stock Research Links

GSTC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bud Ecosystem Debuts AIOS, Aims to Slash Costs

Updated Category News Views 4

AI Fragmentation Tax: Cut It Out! Look, if you think AI is all about fancy algorithms and self-learning voodoo, you're missing the plot. It's the nuts and bolts—the infrastructure—that's been bleeding enterprises dry. That's where Bud Ecosystem comes thrashing in with its Novaria AIOS. They're not just promising a tiny tune-up; they're talking slashing AI costs by a...

Continue Reading
Metriport Eyes Major Step in Health Data Integration

Updated Category News Views 3

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Continue Reading
EnGenius Names Experienced VP to Boost Sales Growth

Updated Category News Views 0

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

Continue Reading
Guaranteed Roof Expands with EM Exteriors through LB Capital

Updated Category News Views 0

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Continue Reading
EmpowHer Grants Propel Female-led Social Ventures Forward

Updated Category News Views 0

Every now and then, you stumble upon a story that makes you take off your trading hat and put on your 'citizen of the world' one. The Boundless Futures Foundation is doing just that, pushing past the $1.5 million mark in grant funding to back female founders creating real scale impact. If this doesn't sound like a nonprofit turning the gears of change, I don't know what...

Continue Reading
AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Updated Category News Views 2

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Continue Reading
Andover Audio's FreePlay: Stereo Sound Goes Portable

Updated Category News Views 3

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

Continue Reading
Chad Tucker's Sequel Explores Deep Spiritual Themes

Updated Category News Views 2

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

Continue Reading
American Savings Bank Surges 6% on NYSE Debut

Updated Category News Views 0

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...

Continue Reading
Beetles Gel Polish Unveils Vibrant Fall Nail Carnival

Updated Category News Views 0

Beetles Gel Polish Launches Fall Nail Carnival Here comes a new twist on fall fashion, and no, it ain’t your grandma's knitted sweater. We're talking nail polish—a vibrant, flashy ordeal brought to you by Beetles Gel Polish with their Fall Nail Carnival. They're rolling out this spectacle not just for your visions of grandeur nail ideas, but for those seeking deals...

Continue Reading

Top 5 Most Recently Viewed Articles

Stock Movements: Microsoft and Nvidia Lead Gains Amid Losses

Updated Category News Views 187

Overview of Stock Market Movements US stock futures exhibited a stable trend recently as investors remained vigilant in anticipation of upcoming employment data and insights from the latest Federal Reserve policy-setting meeting. Key Market Losers Exxon Mobil's Decline Exxon Mobil (NYSE: XOM) saw its stock drop by 0.7%, following a warning concerning a decline in oil...

Continue Reading
Central Banks Face New Stability Risks from AI Technologies

Updated Category News Views 184

Central Banks Must Adapt to Evolving Technological Risks In recent discussions, Bank of Japan Governor Kazuo Ueda has highlighted significant concerns regarding the intersection of artificial intelligence (AI) and financial stability. As central banks navigate the complexities of a rapidly changing financial landscape, Ueda's insights serve as a crucial reminder of the...

Continue Reading
H2O America Delivers Strong Q3 Results with Continued Growth

Updated Category News Views 254

H2O America Reports Impressive Third Quarter Results H2O America (NASDAQ: HTO) has announced its financial results for the third quarter of 2025, showcasing remarkable growth and strategic advances in the water utility sector. The reported diluted EPS reached $1.27, reflecting an 8% increase in adjusted diluted EPS from the previous year. Key Financial Highlights As part...

Continue Reading
Sesame Software Achieves SOC 2 Compliance, Ensuring Data Security for 2025

Updated Category News Views 174

Sesame Software Milestone: Achieving SOC 2 Level 1 Compliance Sesame Software, a leader in innovative data integration and backup solutions, proudly announces its successful achievement of SOC 2 Level 1 compliance. This milestone is a testament to the company's unwavering commitment to protecting customer data and maintaining the highest standards of information security...

Continue Reading
Bio-Techne Introduces Innovative Protein Detection Program

Updated Category News Views 248

Bio-Techne Unveils Groundbreaking Protein Proximity Program New assay enables high-resolution spatial visualization of protein interactions, unlocking functional insights within complex tissues Today, Bio-Techne Corporation (NASDAQ: TECH), a prominent name in the life science tools sector, has revealed an exciting Early Access Program. This initiative focuses on a...

Continue Reading